Based on 3 analysts offering 12 month price targets for Satellos Bioscience Inc
Min Forecast
$11.00+51.52%
Avg Forecast
$18.00+147.93%
Max Forecast
$23.00+216.8%
Should I buy or sell MSLE stock?
Based on 3 analysts offering ratings for Satellos Bioscience Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MSLE's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MSLE as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More
Be the first to know when Wall Street analysts revise their MSLE stock forecasts and price targets.
Is Satellos Bioscience Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: MSLE) stock is to Strong Buy MSLE stock.
Out of 3 analysts, 1 (33.33%) are recommending MSLE as a Strong Buy, 2 (66.67%) are recommending MSLE as a Buy, 0 (0%) are recommending MSLE as a Hold, 0 (0%) are recommending MSLE as a Sell, and 0 (0%) are recommending MSLE as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year MSLE price target, the average MSLE price target is $18.00, with the highest MSLE stock price forecast at $23.00 and the lowest MSLE stock price forecast at $11.00.
On average, Wall Street analysts predict that Satellos Bioscience's share price could reach $18.00 by Apr 28, 2027. The average Satellos Bioscience stock price prediction forecasts a potential upside of 147.93% from the current MSLE share price of $7.26.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.